Ocugen to Host Conference Call to Discuss Third Quarter Results and Recent Business Highlights

Ocugen to Host Conference Call to Discuss Third Quarter Results and Recent Business Highlights

MALVERN, PA — Ocugen, Inc., (NASDAQ: OCGN), a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases, announced that it will release corporate and financial results for the third quarter that ended September 30, 2019 before the open of the U.S. financial markets on Friday, November 8, 2019.

The company will host a conference call at 8:30 a.m. ET on the same day to discuss the results and recent business highlights.

The call can be accessed by dialing (844) 987-9316 (domestic) or (602) 563-8454 (international) and providing the conference ID 9979278. To access a live audio webcast of the call on the “Investors” section of the Ocugen website, please click here. A replay of the webcast will be archived on Ocugen’s website for approximately 45 days following the call.

READ:  BioTelemetry, Inc. Announces Sales Agent Agreement with Boston Scientific Corporation

Source: Ocugen, Inc., 5 Great Valley Parkway, Suite 160, Malvern PA 19355

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee